文献速递间质性肺疾病慢阻肺

肺纤维化合并肺气肿的患病率、检测与轨迹

Prevalence, Detection, and Trajectory of Combined Pulmonary Fibrosis and Emphysema.
PubMed 文献 · Chest · 2026-07-30

该研究基于前瞻性注册队列,纳入接受标准化高分辨率CT视觉评估的IPF和非IPF纤维化ILD患者,发现CPFE患病率在IPF为20%、非IPF纤维化ILD为7%。气流阻塞指标检测CT肺气肿敏感性低但特异性高,CPFE指数与CT肺气肿程度中度相关但一致性差。CT肺气肿程度≥20%与肺功能轨迹差异及更差的无移植生存相关,肺气肿亚型与健康结局无显著关系。

要点

  • IPF患者CPFE患病率为20%,非IPF纤维化ILD为7%。
  • FEV1/FVC低于LLN或<0.70检测CT肺气肿敏感性低但特异性高。
  • CT肺气肿程度≥20%与更差的无移植生存相关。

核心结论

  • 合并肺气肿在IPF和非IPF纤维化ILD中均重要,CT肺气肿程度≥20%与更差健康结局相关。
  • 识别纤维化ILD患者合并肺气肿需要生理学和影像学评估。

研究设计与样本

  • 连续纳入前瞻性注册队列中接受基线胸部高分辨率CT标准化视觉评估的IPF和非IPF纤维化ILD患者。
  • CPFE定义为CT肺气肿程度≥15%,并采用≥5%、≥10%、≥20%阈值进行敏感性分析。
  • CPFE指数基于肺量计和肺一氧化碳弥散量测量推导。

主要发现

  • 基线CPFE患病率在IPF为20%(92/455),在非IPF纤维化ILD为7%(84/1121)。
  • FEV1/FVC低于正常下限和<0.70检测CT肺气肿的敏感性在IPF为11.1%-18.9%、非IPF纤维化ILD为13.1%-23.7%,特异性在IPF为96.2%-98.8%、非IPF纤维化ILD为92.8%-95.8%。
  • CPFE指数与CT肺气肿程度在IPF(r=0.48)和非IPF纤维化ILD(r=0.41)中呈中度相关,但Bland-Altman分析一致性差且 limits of agreement 宽。
  • CT肺气肿程度≥20%与IPF和非IPF纤维化ILD的肺功能轨迹差异及更差的无移植生存一致相关。
  • 肺气肿亚型与健康结局之间未观察到显著关系。

关键数值与推荐

  • CPFE定义为CT肺气肿程度≥15%。
  • 敏感性分析采用CT肺气肿程度≥5%、≥10%、≥20%阈值。
  • CT肺气肿程度≥20%与更差的无移植生存相关。

临床怎么用

  • 在纤维化ILD患者中应结合生理学和影像学评估识别合并肺气肿。
  • CT肺气肿程度≥20%可能提示更差的无移植生存,需加强随访。
  • 气流阻塞指标单独用于检测肺气肿敏感性低,不宜作为唯一筛查手段。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Combined pulmonary fibrosis and emphysema (CPFE) is an important phenotype in patients with fibrotic interstitial lung disease (ILD). RESEARCH QUESTION: What is the prevalence of CPFE? What is the predictive performance of the CPFE index and of physiologic airflow obstruction for CT imaging emphysema extents? Is the extent of emphysema on CT imaging associated with outcomes in patients with fibrotic ILD? STUDY DESIGN AND METHODS: Consecutive patients with idiopathic pulmonary fibrosis (IPF) and non-IPF fibrotic ILD who underwent a standardized visual assessment of the baseline high-resolution CT imaging of the chest from a prospective registry were included. CPFE was defined as emphysema extent of ≥ 15% on CT imaging, with sensitivity analyses using different thresholds: ≥ 5%, ≥ 10%, and ≥ 20%. Emphysema subtypes were categorized based on their predominant distribution: centrilobular, paraseptal, or panlobular. The CPFE index was derived using measurements of spirometry and diffusion capacity of the lungs for CO2. RESULTS: The prevalence of CPFE at baseline was 20% for IPF (92/455) and 7% in non-IPF fibrotic ILD (84/1121). Both FEV1 to FVC ratio less than the lower limit of normal and < 0.70 showed poor sensitivity (IPF, 11.1%-18.9%; non-IPF fibrotic ILD, 13.1%-23.7%) for detecting emphysema on CT imaging, although high specificity (IPF, 96.2%-98.8%; non-IPF fibrotic ILD, 92.8%-95.8%). The CPFE index was correlated moderately with extent of emphysema on CT imaging in both IPF (r = 0.48) and non-IPF fibrotic ILD (r = 0.41), but with poor agreement and wide limits of agreement on Bland-Altman analysis. Extent of emphysema on CT imaging of ≥ 20% was associated consistently with differences in lung function trajectories and worse transplant-free survival in IPF and non-IPF fibrotic ILD. No significant relationships were noted between emphysema subtypes and health outcomes. INTERPRETATION: Our results show that coexisting emphysema is important in both IPF and non-IPF fibrotic ILD, with extent of emphysema on CT imaging of ≥ 20% being associated with worse health outcomes. Both physiologic and radiologic assessments are needed to identify coexistent emphysema in patients with fibrotic ILD.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Khor YH, Marinescu DC, Manganas H, et al. Prevalence, Detection, and Trajectory of Combined Pulmonary Fibrosis and Emphysema. Chest. 2026. PMID: 42413722. doi:10.1016/j.chest.2026.05.051

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。